Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Abbv105
2. Elsubrutinib [inn]
3. Abbv-105
4. Elsubrutinib [usan]
5. 1643570-24-4
6. (s)-4-(1-acryloylpiperidin-3-yl)-1h-indole-7-carboxamide
7. 1487u1q3iq
8. 4-[(3s)-1-prop-2-enoylpiperidin-3-yl]-1h-indole-7-carboxamide
9. 1h-indole-7-carboxamide, 4-((3s)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl)-
10. Starbld0001577
11. Elsubrutinib [usan:inn]
12. Unii-1487u1q3iq
13. Chembl4594348
14. Schembl16337209
15. Gtpl10464
16. Bdbm50557484
17. Who 11113
18. Zinc220885814
19. Hy-109143
20. Cs-0115958
21. Example #30 (s) [wo2014210255a1]
22. 4-((3s)-1-(prop-2-enoyl)-piperidin-3-yl)-1h-indole-7-carboxamide
23. 1953227-31-0
| Molecular Weight | 297.35 g/mol |
|---|---|
| Molecular Formula | C17H19N3O2 |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 79.2 |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 465 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Elsubrutinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elsubrutinib, including repackagers and relabelers. The FDA regulates Elsubrutinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elsubrutinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Elsubrutinib supplier is an individual or a company that provides Elsubrutinib active pharmaceutical ingredient (API) or Elsubrutinib finished formulations upon request. The Elsubrutinib suppliers may include Elsubrutinib API manufacturers, exporters, distributors and traders.
Elsubrutinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Elsubrutinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Elsubrutinib GMP manufacturer or Elsubrutinib GMP API supplier for your needs.
A Elsubrutinib CoA (Certificate of Analysis) is a formal document that attests to Elsubrutinib's compliance with Elsubrutinib specifications and serves as a tool for batch-level quality control.
Elsubrutinib CoA mostly includes findings from lab analyses of a specific batch. For each Elsubrutinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Elsubrutinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Elsubrutinib EP), Elsubrutinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Elsubrutinib USP).
LOOKING FOR A SUPPLIER?
